Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease

Gelijkaardige items

• Anti-tumour necrosis factor α monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome
  door: Licata, G, et al.
  Gepubliceerd in: (2003)
• Vγ9/Vδ2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor β(1 )expression in active disease
  door: Triolo, Giovanni, et al.
  Gepubliceerd in: (2003)
• Humoral and cell mediated immune response to cow's milk proteins in Behçet's disease
  door: Triolo, G, et al.
  Gepubliceerd in: (2002)
• IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells
  door: Triolo, G, et al.
  Gepubliceerd in: (1998)
• Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity
  door: Accardo-Palumbo, Antonina, et al.
  Gepubliceerd in: (2010)